(Q59587665)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12063004%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12063004%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12063004%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Frank J Lagerwaard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12063004%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Jan P van Meerbeeck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12063004%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Wilfried J Graveland

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12063004%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Rotterdam Oncological Thoracic Study Group

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12063004%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12063004%20AND%20SRC:MED&resulttype=core&format=json

Radiotherapy and Oncology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12063004%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12063004%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12063004%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

151-157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12063004%20AND%20SRC:MED&resulttype=core&format=json

Involved-field radiotherapy alone for early-stage non-small-cell lung cancer

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Medically Inoperable Lung Carcinoma: The Role of Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Three-Dimensional Conformal Radiation Therapy In Bronchogenic Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

The curative treatment by radiation therapy alone of Stage I non-small cell lung cancer in a geriatric population

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Radical radiotherapy for early nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Induction therapy for stage III NSCLC: a consensus report

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Radiation therapy alone for stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Multiple “slow” CT scans for incorporating lung tumor mobility in radiotheraphy planning

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

73.6 Gy and beyond: hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Dose escalation of chart in non-small cell lung cancer: is three-dimensional conformal radiation therapy really necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Respiratory gated irradiation system for heavy-ion radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Impact of respiratory movement on the computed tomographic images of small lung tumors in three-dimensional (3D) radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Dosimetric consequences of tumor mobility in radiotherapy of stage I non-small cell lung cancer--an analysis of data generated using 'slow' CT scans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Curative radiotherapy for technically operable stage I nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900009-9

7 January 2021

10.1016/S0167-8140(02)00009-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12063004%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference